全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

青年肺癌与老年肺癌的临床特征对比分析
Comparative Analysis of the Clinical Features of Lung Cancer between Young and Old Patients

DOI: 10.12677/ACM.2020.107185, PP. 1205-1210

Keywords: 肺肿瘤,青年人,老年人,临床特征
Lung Neoplasms
, Young People, Old People, Clinical Features

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探讨青年肺癌与老年肺癌患者的临床特征。方法:选取2016年1月至2019年6月期间收治的120例≤40岁的肺癌患者作为青年组,另随机选取118例≥70岁的同期肺癌患者作为老年组,比较两组患者的临床特征。结果:青年肺癌患者以无吸烟史多见,老年肺癌患者以有吸烟史多见(P < 0.001)。两组患者均以男性、腺癌、III~IV期临床分期为主;青年组女性、腺癌、III~IV期临床分期患者比例均高于老年组,老年组鳞癌患者比例高于青年组(P均 < 0.05)。老年组EGFR突变率高于青年组,青年组ALK重排阳性率高于老年组(P均 < 0.05)。青年组EGFR 19外显子突变率高于老年组(P < 0.05)。两组患者在肺癌家族史方面差异无统计学意义(P > 0.05)。结论:青年肺癌女性、不吸烟者、腺癌、III~IV期临床分期患者比例较高,ALK重排阳性率较高,EGFR 19外显子突变率较高;老年肺癌吸烟者、鳞癌患者比例较高,EGFR突变率较高,临床工作中应适当参考这些特征,以做到肺癌的早期诊断及有效治疗。
Objective: To explore the clinical features of lung caner in young and old patients. Methods: From January 2016 to June 2019, 120 patients (≤40 years) with lung cancer were selected as the youth group and 118 patients (≥70 years) with lung cancer were selected randomly as the elderly group during the same period. The clinical features were compared between the two groups. Results: Majority of young patients with lung cancer were non-smokers while most elderly patients were smokers (P < 0.001). Patients of two groups both were characterized by males over-representation, adenocarcinoma and stage III - IV. The proportion of females, adenocarcinoma and stage III - IV in the youth group was higher than that in the elderly group (P < 0.05). The proportion of squamous carcinoma in the elderly group was higher than that in the youth group (P < 0.05). The proportion of EGFR gene mutations in the elderly group was higher than that in the youth group (P < 0.05). The proportion of ALK gene rearrangements in the youth group was higher than that in the elderly group (P < 0.05). The proportion of EGFR exon 19 mutations in the youth group was higher than that in the elderly group (P < 0.05). No significant difference was found between the two groups in terms of family history of lung cancer (P > 0.05). Conclusion: Lung cancer in young patients is connected with higher proportion of females, non-smokers, adenocarcinoma, stage III - IV, ALK gene rearrangements and EGFR exon 19 mutations. Lung cancer in old patients is connected with higher proportion of smokers, squamous carcinoma and EGFR gene mutations. We should be aware of these characteristics to achieve the early diagnosis and effective treatment of lung caner.

References

[1]  Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
[2]  Thomas, A., Chen, Y., Yu, T., et al. (2015) Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States. Frontiers in Oncology, 5, 113.
https://doi.org/10.3389/fonc.2015.00113
[3]  Li, J., Yang, F., Li, X., et al. (2017) Characteristics, Survival, and Risk Factors of Chinese Young Lung Cancer Patients: The Experience from Two Institutions. Oncotarget, 8, 89236-89244.
https://doi.org/10.18632/oncotarget.19183
[4]  Abbasowa, L. (2016) Lung Cancer in Younger Patients. Danish Medical Journal, 63, A5248.
[5]  Bigay-Gamé, L., Bota, S., Greillier, L., et al. (2018) Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France. Oncology, 95, 337-343.
https://doi.org/10.1159/000489784
[6]  Xia, J., Li, H., Ji, Y., et al. (2019) Clinicopathologic Characteristics and EGFR Mutations in Lung Cancer Patients Aged below 45 Years. Current Problems in Cancer, 43, 363-370.
https://doi.org/10.1016/j.currproblcancer.2018.11.003
[7]  Mousavi, S.M., Schmid, S. and Cerny, T. (2018) Lung Cancer and Smoking Trends in the Young in Switzerland: A Study Based on Data of the National Institute for Cancer Epidemiology and Registration and of the Swiss Health Surveys. Swiss Medical Weekly, 148, w14708.
https://doi.org/10.4414/smw.2018.14708
[8]  Liam, C.-K., Lim, K.-H. and Wong, C.M.-M. (2000) Lung Cancer in Patients Younger than 40 Years in a Multiracial Asian Country. Respirology, 5, 355-361.
https://doi.org/10.1111/j.1440-1843.2000.00275.x
[9]  Kuo, C.-W., Chen, Y.-M., Chao, J.-Y., et al. (2000) Non-Small Cell Lung Cancer in Very Young and Very Old Patients. Chest, 117, 354-357.
https://doi.org/10.1378/chest.117.2.354
[10]  Alberg, A.J., Ford, J.G. and Samet, J.M. (2007) Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest, 132, 29S-55S.
https://doi.org/10.1378/chest.07-1347
[11]  Liu, B., Quan, X., Xu, C., et al. (2019) Lung Cancer in Young Adults Aged 35 Years or Younger: A Full-Scale Analysis and Review. Journal of Cancer, 10, 3553-3559.
https://doi.org/10.7150/jca.27490
[12]  Yang, L., Yuan, Y., Sun, T., et al. (2015) Population-Based Cancer Incidence Analysis in Beijing, 2008-2012. Chinese Journal of Cancer Research, 27, 13-21.
[13]  张长海. 老年肺癌与中青年肺癌的临床特点分析[J]. 现代肿瘤医学, 2015, 23(14): 1983-1985.
[14]  Gibson, A.J., D’Silva, A., Elegbede, A.A., et al. (2019) Impact of Asian Ethnicity on Outcome in Metastatic EGFR- Mutant Non-Small Cell Lung Cancer. Asia-Pacific Journal of Clinical Oncology, 15, 343-352.
https://doi.org/10.1111/ajco.13234
[15]  Herbst, R.S., Morgensztern, D. and Boshoff, C. (2018) The Biology and Management of Non-Small Cell Lung Cancer. Nature, 553, 446-454.
https://doi.org/10.1038/nature25183
[16]  Zhang, H., Cai, W., Wang, Y., et al. (2019) CT and Clinical Characteristics That Predict Risk of EGFR Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. International Journal of Clinical Oncology, 24, 649-659.
https://doi.org/10.1007/s10147-019-01403-3
[17]  Hsu, C.H., Tseng, C.H., Chiang, C.J., et al. (2016) Characteristics of Young Lung Cancer: Analysis of Taiwan’s Nationwide Lung Cancer Registry Focusing on Epidermal Growth Factor Receptor Mutation and Smoking Status. Oncotarget, 7, 46628-46635.
https://doi.org/10.18632/oncotarget.9338
[18]  Zhong, W., Zhao, J., Huang, K., et al. (2018) Comparison of Clinicopathological and Molecular Features between Young and Old Patients with Lung Cancer. International Journal of Clinical and Experimental Pathology, 11, 1031-1035.
[19]  Deng, H., Li, B., Li, L., et al. (2019) Clinical Observation of Crizotinib in the Treatment of ALK-Positive Advanced Non-Small Cell Lung Cancer. Pathology, Research and Practice, 215, 152695.
https://doi.org/10.1016/j.prp.2019.152695

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133